BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $120 at TD Cowen
Tweet Send to a Friend
TD Cowen analyst Phil Nadeau lowered the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $120.00 (from $125.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
